Family Planning Cooperative Purchasing Program
A non-profit purchasing collaborative for health care & community organizations
Save 25% on CFHC Materials
FPCPP members get 25% off CFHC's health education materials. Visit the online store now.
Not a member yet? Sign up now!
What's New
- All in One - Contraceptive Educator Kit from Total Access Group
- Save 10% off your order with Office Depot
- New Supply Partner: SecuReach
- Direct Relief USA Offer of Lo Seasonique
- An Important Drug Recall from Glenmark Generics
- Office Depot - Store Purchasing Card (SPC)
- The DeTec One Step Early Pregnancy Test Kit
- FemCap Promotion
- An Important Drug Recall - LO/OVRAL-28 and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mg Tablets
- Daily-Vite from R&S Northeast
Categories
- Abortion
- Administrative Supplies
- Barriers
- Cancer
- CFHC
- Condoms
- Conference
- Contraception
- Contraceptives
- Cooperative Audio Clips
- Cooperative Updates
- Coupons
- Cycle Beads
- Diagnostic & Pregnancy Tests
- Educational
- Femcap
- Glenmark-Generics
- GovConnection
- Health Care
- HIV/AIDS
- Medical Access
- News
- Office Depot
- Oral Contraceptives
- OraSure
- Pharmaceutical Products
- Pharmaceuticals
- Public Policy
- R&S Northeast
- Sales
- Special Occasions
- STD
- Teen Pregnancy
- Total Access Group
- Travel
- Vendors
- Videos
- Watson
- Women’s Health
Powered by
January 17, 2012
An Important Drug Recall - LO/OVRAL-28 and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mg Tablets
Following is a Pfizer generated document we received on Friday, January 13, 2012:
Pfizer Inc. is recalling multiple lots of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mgTablets manufactured and packaged by Pfizer, and distributed and commercialized by Akrimax Pharmaceuticals, LLC (see below for lot numbers and expiration dates). Please note that these products are labeled with Akrimax labeling. Pfizer Inc. voluntarily initiated this recall when it was determined that some blister packs may contain an inexact count of placebo or active ingredient tablets. Please note that use of this product is not likely to cause adverse health consequences.
FEDERAL REGULATIONS REQUIRE THAT YOU RESPOND TO THIS RECALL, EVEN IF YOU DO NOT HAVE THE RECALLED PRODUCT. TO RESPOND, PLEASE CONTACT STERICYCLE INC. AT 1(800)-805-3093 WITHIN FIVE (5) BUSINESS DAYS.
The recall of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03 mg Tablets is being conducted to the retail level.
Records indicate that you may have received shipment of affected lots between January 2011 and December 2011. Please check your stock immediately against the table below. If you have any of the affected products in your inventory, please stop distribution and promptly return to Stericycle Inc. 2670 Executive Drive, Suite A Indianapolis, IN 46241: Attn: Event 2568. Please contact Stericycle Inc. at (800) 805-3093 if you require the pre-paid UPS labels. If you have any medical inquiries regarding these products, please contact Akrimax Medical Information at 1(877)509-3935 (8 AM to 7 PM Mon-Fri CST).
If you have further distributed the lots to the retail level, please conduct a sub-recall and communicate this recall information to those accounts immediately. Please request that they immediately cease distribution of the affected lots and promptly return the product directly to the above address. If they have inventory of the affected product, they can contact Stericycle Inc. at (800) 805-3093 to obtain pre-paid shipping labels for product return. Further authorization is not required for product return. Reimbursement for the returned product will be made by credit memorandum. If you have any questions regarding the reimbursement, please contact your Akrimax Customer Service Representative at 1(877) 509-3935 (8 AM to 7 PM Mon-Fri CST).
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. We appreciate your immediate attention and cooperation to this matter.
LO/OVRAL® - 28
LOT# Expiration Date
E15678 8/31/2013
E15679 8/31/2013
E15686 8/31/2013
E15687 1/31/2014
E15690 1/31/2014
E15698 1/31/2014
E15700 2/28/2014
E80434 7/31/2013
E80438 8/31/2013
F36908 2/28/2014
F36909 2/28/2014
F43915 3/31/2014
F43926 3/31/2014
F43927 3/31/2014
NORGESTREL 0.3MG/ETHINYL ESTRADIOL 0.03 MG
LOT# Expiration Date
E15677 8/31/2013
E15704 1/31/2014
E15706 1/31/2014
E80440 8/31/2013
F16388 1/31/2014
F16390 2/28/2014
F22132 2/28/2014
F31330 2/28/2014
F36911 3/31/2014
F36913 3/31/2014
F43924 3/31/2014
F43925 3/31/2014
F43934 3/31/2014
F53238 3/31/2014
September 30, 2011
Introducing the Contraceptive Educator Kit from Total Access Group
We've been getting alot of inquiries from folks we meet at conferences about educator kits. The Cooperative Purchasing Program has partnered with Total Access Group to provide these valuable educator kits to our members. And now, they have the new and improved Contraceptive Educator Kit available for the great price of $129.00, which includes an array of contraceptives and demonstration models.
Contraceptive Educator Kit
Total Access Group has the original basic Educator Kit and the Contraceptive Educator Kit available for purchase. To place your order, please contact Total Access Group at (800) 320-3716, and be sure to mention that you're a member of the Cooperative Purchasing Program.
For more information on the different types of Educator Kits Total Access carries, please click HERE to watch the video.
June 03, 2009
Review of Studies of IUD Use in Adolescents Finds Favorable Results, Limited Body of Research
Public Release Date: 28-May-2009
Summary of "Intrauterine Devices for Adolescents: a Systematic Review," Deans/Grimes, Contraception, June 2009.
Adolescent pregnancy persists as a "stubborn" public health problem in the U.S., with teenagers accounting for nearly 750,000 pregnancies annually, about 82% of which are unintended. Although adolescents have higher continuation rates with longer-acting contraceptive methods, the majority of them use oral contraceptives and condoms. Adolescents' compliance with shorter-acting methods is mediocre, and many could benefit from methods that are simpler to use and longer-lasting, according to the researchers.
March 26, 2008
Study Examines Diaphragm Use, Acceptability for STI Prevention
Public Release Date: 20-March-2008
Abstract of "Evidence-Based Planning of a Randomized Controlled Trial on Diaphragm Use for Prevention of Sexually Transmitted Infections," Behets et al. Sexually Transmitted Diseases, March 2008.
Frieda Behets of the University of North Carolina-Chapel Hill and colleagues examined whether commercial sex workers in Madagascar would accept and use a diaphragm to prevent sexually transmitted infections in an effort to determine potential obstacles in future research on the effectiveness of a diaphragm for use in STI prevention.
Continue reading "Study Examines Diaphragm Use, Acceptability for STI Prevention"
February 13, 2008
Kroger Launches Discount Drug Program, Includes Generic Birth Control
Public Release Date: 7-February-2008
On Wednesday, the Cincinnati-based Kroger announced that it will begin selling 30-day supplies of more than 300 generic prescription drugs, including birth control pills, at significant discounts at participating pharmacies nationwide, the Atlanta Journal-Constitution reports.
Continue reading "Kroger Launches Discount Drug Program, Includes Generic Birth Control"
January 16, 2008
FemCap's HIV Prevention Presentation
Alfred Shihata of FemCap gave a presentation at the HIV Prevention Conference in Atlana last month, and was kind enough to share it with us!
Click here to see the presentation!
July 31, 2007
Synova Launches Advertising Campaign for Today Sponge Contraceptive
Public Release Date: 31-July-2007
Synova Healthcare recently launched a new Web site and an advertising campaign to market the Today Sponge female contraceptive in the U.S., the New York Times reports (Levere, New York Times, 7/30).
The sponge, which is constructed of soft polyurethane foam and is inserted into the vagina for up to 24 hours, provides barrier protection and the spermicide nonoxynol-9 to prevent pregnancy. The device is 89% to 91% effective in preventing pregnancy but does not protect against sexually transmitted infections.
Continue reading "Synova Launches Advertising Campaign for Today Sponge Contraceptive "
May 10, 2007
ACOG: Plan B Availability Varies from State to State
Public Release Date: 9-May-2007
SAN DIEGO -- Those who battled the FDA for non-prescription status of Plan B (levonorgestrel) apparently won only half the struggle. Prescription or not, Plan B can be hard to get.
A survey of Plan B availability in three major cities found that state laws can override the ease of access to the emergency contraception agent, whether by prescription or "under-the-counter" sales.
Continue reading "ACOG: Plan B Availability Varies from State to State"
